Value-Based Cancer Care Issues


February 2012, Vol 3, No 1

Ventura County Hematology Oncology Specialists: Efficiencies Crucial for Economic Viability

Best Practices

Ventura County Hematology Oncology Specialists has so far managed to avoid many of the financial difficulties facing a large number of community cancer practices. Value-Based Cancer Care asked Dr Parsa and Ms Rivera to discuss what makes their practice successful from a clinical and a business perspective.

VBCC: When was the practice established, and what are some of the services you offer?

[ Read More ]

Bosutinib Shows Superior Results in CML

Neil Canavan

ASH Annual Meeting

San Diego, CA—The newest data presented from the BELA (Bosutinib Efficacy and Safety in Chronic Myeloid Leukemia) trial show a superior cumulative complete cytogenetic response rate (CCyR) for bosutinib versus the standard-of-care agent, imatinib, when used as frontline treatment for patients with chronic myeloid leukemia (CML), with 87% and 81% response rates at 24 months.